CSTL — CASTLE BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1447362 ·
Last close
$35.93
Market Cap
$1.10B
52W High
$44.28
52W Low
$17.72
ADV30
356,367
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 103,546,000 | 79,846,000 | -3,070,000 | -2,060,000 | 561,177,000 | 62,116,000 | 91,147,000 |
| Mar 2026 | 83,679,000 | 63,146,000 | -18,407,000 | -14,522,000 | 547,805,000 | 63,764,000 | 86,389,000 |
| Dec 2025 | 87,010,000 | 68,695,000 | -3,827,000 | -2,332,000 | 578,556,000 | 116,729,000 | 107,683,000 |
| Sep 2025 | 83,043,000 | 64,339,000 | -6,804,000 | -501,000 | 562,786,000 | 85,556,000 | 95,740,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$42,634,000
Investing CF
$-51,324,000
Financing CF
$-11,427,000
CapEx
$-43,123,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.66
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-240,866,000
Inventory
$10,580,000
Receivables
$48,341,000
ST Investments
$204,689,000
EBIT TTM
$-18,828,000
Pretax Income TTM
$-19,203,000
Interest Exp TTM
$375,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$357,278,016
EBITDA
$-16,516,000
Free Cash Flow
$-7,256,375
Enterprise Value
$757,510,592
Total Cash
$266,804,992
Total Debt
$36,650,000
Shares Out
30,549,507
Trailing EPS
$-0.64
Book Value
$15.41
ROE
-4.2%
ROA
-1.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 344,229,000 | -42,810,000 | -24,158,000 | 578,556,000 | 107,683,000 | 470,873,000 | 64,347,000 |
| Dec 2024 | 332,069,000 | 8,670,000 | 18,245,000 | 531,235,000 | 75,400,000 | 455,835,000 | 64,866,000 |
| Dec 2023 | 219,788,000 | -67,977,000 | -57,466,000 | 453,340,000 | 62,071,000 | 391,269,000 | -5,626,000 |
| Dec 2022 | 137,039,000 | -91,142,000 | -67,138,000 | 447,329,000 | 48,179,000 | 399,150,000 | -41,655,000 |
TTM Snapshot
Revenues TTM
$208,981,000
NetIncome TTM
$-30,025,000
OpCashFlow TTM
$0
Assets (Latest)
$531,235,000
Forward EPS
$-0.99
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TDOC | Teladoc Health, Inc. | $1.07B | $5.89 | — |
| OMDA | Omada Health, Inc. | $1.19B | $19.39 | — |
| INNV | InnovAge Holding Corp. | $1.21B | $8.89 | — |
| LMRI | Lumexa Imaging Holdings, Inc. | $974.68M | $10.15 | — |
| USPH | U S PHYSICAL THERAPY INC /NV | $1.28B | $86.09 | — |
News headlines (Yahoo Finance, 1h cache)
New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
2026-09-28 11:00 · Yahoo
New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™
2026-09-24 20:30 · Yahoo
Castle Biosciences to Open New Laboratory Facility in Scottsdale
2026-09-22 11:00 · Yahoo
New Decision Modeling Study Demonstrates TissueCypher® Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus
2026-09-15 11:00 · Yahoo
JAAD Publication Shows Improved Performance of DecisionDx®-SCC
2026-09-09 20:30 · Yahoo
Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know
2026-08-28 16:00 · Yahoo
Castle Biosciences (CSTL) Rallies On Earnings Optimism, Is The Stock Still Cheap?
2026-08-27 01:10 · Yahoo
Castle Biosciences to Participate in Upcoming Investor Conferences
2026-08-20 11:00 · Yahoo
Castle Biosciences Approved for Dual Listing on Nasdaq Texas
2026-08-17 11:00 · Yahoo
Castle Biosciences Raises Outlook as Melanoma, TissueCypher Tests Gain Traction
2026-08-13 05:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.